<?xml version="1.0" encoding="UTF-8"?>
<p id="p0220">Moreover, this effect is not restricted to tetanus but is adaptable to other pathogens as well and then the principle could be applied to other vaccine formulations. Polioboostrix is a tetravalent vaccine with a high coverage of 85% of infants immunized, making it an attractive study model 
 <xref rid="b0070" ref-type="bibr">[14]</xref> as suggested by Tahtinen and colleagues 
 <xref rid="b0030" ref-type="bibr">[6]</xref>.
</p>
